Integral Developments

The path from conception to implementation is rarely linear. Integral Developments highlights how medical innovations emerge to support human healthspan. What lessons from past innovations can we apply to accelerate progress?

About Egan Peltan

I am a chemical biologist and early-stage pharmaceutical entrepreneur. I’m interested in medical progress, how we get drugs, and from where medical innovation emerges. For me, writing is a great opportunity to explore topics that spark my curiosity in-depth and share those learnings.

I’m currently working on a stealth-mode startup to support physical function in older adults. I enjoy working on pharmaceuticals because once drugs are discovered, their impact grows over time. In that vein, work on geriatric medicine because I bleive it has one of the highest impacts at the margin, yet remains broadly neglected by the pharmaceutical industry. I hope to convince the world that physical function merits the same attention that cognitive function gets.

Prior to co-founding the company, I completed a PhD at Stanford in the lab of Carolyn Bertozzi focused on applications of glycobiology and characterizing antibodies directed towards tumor-associated neoglycoantigens. At Stanford, I also co-led the Stanford Biotech Group, a student-run group connecting the Biotech (broadly defined) industry with the Stanford community.

Stay up-to-date

Never miss an update—every new post is sent directly to your email inbox. For a spam-free, ad-free reading experience, subscribe below.